First Wave BioPharma

+$0.20 (+7.11%) As of 7:49 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FWBI and other ETFs, options, and stocks.

About FWBI

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm involves in therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

CEO
James E. Sapirstein
Employees
12
Headquarters
Boca Raton, Florida
Founded
2014

FWBI Key Statistics

Market Cap
28.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
286.49K
High Today
$3.55
Low Today
$2.83
Open Price
$2.90
Volume
19.52M
52 Week High
$26.30
52 Week Low
$2.61

FWBI Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure